VYNE Therapeutics Inc. (VYNE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 24.81M |
| Enterprise Value | 786,993 |
| P/E Ratio | -0.04 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 1.3 |
| Price/Book Ratio | 1.42 |
| Enterprise/Revenue | -46.26 |
| Enterprise/EBITDA | 1.18 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -38.82 |
| Operating Margin | -41.35 |
| Return On Assets | -0.79 |
| Return On Equity | -0.7 |
| Revenue | 570,000 |
| Revenue/Share | 0.56 |
| Gross Profit | 547,000 |
| EBITDA | -26.73M |
| Net Income | -26.48M |
| Diluted EPS | -31 |
| Total Cash | 29,008 |
| Total Cash/Share | 26.72 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 15.26 |
| Book Value Per Share | 25.71 |
| 52-Week Change | 71.02 |
| 52-Week High | 74.47 |
| 52-Week Low | 14.03 |
| Moving Average 50 Days | 34.03 |
| Moving Average 200 Days | 28.6 |
| Average Volume | 16,906 |
| Shares Outstanding | 667,700 |
| % Held by Institutions | 30.77 |
| Trailing Annual Dividend Rate | 20.1 |
| Trailing Annual Dividend Yield | 55.18 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | July 27, 2026 |